Intellia Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Four minutes, just introducing company, giving you a quick overview of where are we and some of the things to bear in mind with respect to Intellia.
Forward-looking statement. In a nutshell, Intellia is a CRISPR/Cas9 gene editing company. What we're building at the organization is something we call a full spectrum genome editing company, I'll talk a little bit about that in the comments to come. But in a nutshell, that really reflects the work that we're doing in the in vivo gene editing side and our work to build world-class engineered cell therapy company as well. A key to thinking about us is that we're doing this work in a modular approach where we solve a variety of different problems, aggregate that technology and put ourselves in a position where we can play that out as we move to various product candidates and gain efficiencies in the process. In the short time that we've been a company in Cambridge, Massachusetts we've made a lot of progress, have very significant in vivo preclinical work that we've done. Some
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
